Monitoring of rotavirus vaccination in Morocco: Establishing the baseline burden of rotavirus disease

Vaccine

Volumn 30, Issue 46, 2012, Pages 6515-6520

  Benhafid, Mohammed ^a,f   Rguig, Ahmed ^b   Trivedi, Tarak ^c   Elqazoui, Maria ^a   Teleb, Nadia ^d,g   Mouane, Nezha ^e,h   Maltouf, Abdelkarim Filali ^f   Parashar, Umesh ^c   Patel, Manish ^c   Aouad, Rajae El ^a  

^a INSTITUT NATIONAL D HYGIÈNE   (Morocco)

^b Ministry of Health Morocco   (Morocco)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e Children Hospital   (Morocco)

^f FACULTÉ DES SCIENCES   (Morocco)

^g WHO/EMRO   (Egypt)

^h Hopital d'Enfants   (Morocco)

Author keywords

Diarrheal deaths; Diarrheal hospitalizations; Morocco; Rotavirus; Rotavirus vaccine

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILD; CHILDHOOD MORTALITY; DIARRHEA; DRUG MONITORING; ENZYME IMMUNOASSAY; FECES ANALYSIS; FEMALE; GASTROENTERITIS; HEALTH PROGRAM; HEALTH SURVEY; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; MOROCCO; PEDIATRICS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; ROTAVIRUS INFECTION; WORLD HEALTH ORGANIZATION;

CHILD, PRESCHOOL; FECES; FEMALE; GASTROENTERITIS; HOSPITALS; HUMANS; IMMUNOASSAY; INFANT; INFANT, NEWBORN; MALE; MOROCCO; PREVALENCE; ROTAVIRUS; ROTAVIRUS INFECTIONS; SURVIVAL ANALYSIS;

EID: 84867009583     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.058     Document Type: Article

References (37)

1. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12(February (2)):136-141.
2. WHO Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009, 84(December (50)):533-540.
3. Armah G.E., Sow S.O., Breiman R.F., Dallas M.J., Tapia M.D., Feikin D.R., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2011, 376(August (9741)):606-614.
4. Jiang V., Jiang B., Tate J., Parashar U.D., Patel M.M. Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin 2010, 6(July (7)):532-542.
5. Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010, 362(January (4)):289-298.
6. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(January (1)):11-22.
7. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(January (1)):23-33.
8. Zaman K., Dang D.A., Victor J.C., Shin S., Yunus M., Dallas M.J., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2011, 376(August (9741)):615-623.
9. Benhafid M., Youbi M., Klena J.D., Gentsch J.R., Teleb N., Widdowson M.A., et al. Epidemiology of rotavirus gastroenteritis among children <5 years of age in Morocco during 1 year of sentinel hospital surveillance, June 2006-May 2007. J Infect Dis 2009, 200(November (Suppl. 1)):S70-S75.
10. Patel M.M., Parashar U.D. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. J Infect Dis 2009, 200(November (Suppl. 1)):S291-S299.
11. WHO Generic protocol for monitoring impact of rotavirus vaccination on rotavirus disease burden and viral strains. Document WHO/IVB/0816 2009, WHO, Geneva, p. 1-73.
12. Gentsch J.R., Laird A.R., Bielfelt B., Griffin D.D., Banyai K., Ramachandran M., et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005, 192(September (Suppl. 1)):S146-S159.
13. Patel M.M., Steele D., Gentsch J.R., Wecker J., Glass R.I., Parashar U.D. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 2011, 30(January (1 Suppl.)):S1-S5.
14. WHO Generic protocols for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. Document WHO/V & B/0215 2002, WHO, Geneva, p. 1-67.
15. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9(May (5)):565-572.
16. Abugalia M., Cuevas L., Kirby A., Dove W., Nakagomi O., Nakagomi T., et al. Clinical features and molecular epidemiology of rotavirus and norovirus infections in Libyan children. J Med Virol 2011, 83(October (10)):1849-1856.
17. Hassine-Zaafrane M., Sdiri-Loulizi K., Ben Salem I., Kaplon J., Ayouni S., Ambert-Balay K., et al. The molecular epidemiology of circulating rotaviruses: three-year surveillance in the region of Monastir, Tunisia. BMC Infect Dis 2011, 11:266.
18. Matson D.O., Abdel-Messih I.A., Schlett C.D., Bok K., Wienkopff T., Wierzba T.F., et al. Rotavirus genotypes among hospitalized children in Egypt, 2000-2002. J Infect Dis 2010, 202(September (Suppl.)):S263-S265.
19. Tayeb H.T., Balkhy H.H., Aljuhani S.M., Elbanyan E., Alalola S., Alshaalan M. Increased prevalence of rotavirus among children associated gastroenteritis in Riyadh Saudi Arabia. Virol J 2011, 8:548.
20. Al Baqlani S., Peenze I., Dewar J., Al Lawati Z., Pearson L., Rupa V., et al. Molecular characterization of rotavirus strains circulating in Oman in 2005. J Infect Dis 2010, 202(September (Suppl.)):S258-S262.
21. Madhi S., Lerumo T., Louw C., Kirsten M., Neuzil K., Steele D., et al. Efficacy of human rotavirus vaccine RIX4414 (Rotarix™) in South African infants during the first year of life - an interim report. Presented at the 8th International Rotavirus Symposium 2008, [abstract].
22. Linhares A.C., Velazquez F.R., Perez-Schael I., Saez-Llorens X., Abate H., Espinoza F., et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008, 371(April (9619)):1181-1189.
23. Pitzer V.E., Viboud C., Lopman B.A., Patel M.M., Parashar U.D., Grenfell B.T. Influence of birth rates and transmission rates on the global seasonality of rotavirus incidence. J R Soc Interface 2011, 8(April (64)):1584-1593.
24. Chouikha A., Fodha I., Noomen S., Bouzid L., Mastouri M., Peenze I., et al. Group A rotavirus strains circulating in the eastern center of Tunisia during a ten-year period (1995-2004). J Med Virol 2007, 79(July (7)):1002-1008.
25. Eesteghamati A., Gouya M., Keshtkar A., Najafi L., Zali M.R., Sanaei M., et al. Sentinel hospital-based surveillance of rotavirus diarrhea in iran. J Infect Dis 2009, 200(November (Suppl. 1)):S244-S247.
26. Ali M.B., Ghenghesh K.S., Aissa R.B., Abuhelfaia A., Dufani M. Etiology of childhood diarrhea in Zliten, Libya. Saudi Med J 2005, 26(November (11)):1759-1765.
27. Al Awaidy S.A., Bawikar S., Al Busaidy S., Baqiani S., Al Abedani I., Varghese R., et al. Considerations for introduction of a rotavirus vaccine in Oman: rotavirus disease and economic burden. J Infect Dis 2009, 200(November (Suppl 1)):S248-S253.
28. Kheyami A.M. Rotavirus gastroenteritis and strain diversity in Saudi Arabia. Current status and future prospects. Saudi Med J 2010, 31(March (3)):276-279.
29. Wierzba T.F., Abdel-Messih I.A., Abu-Elyazeed R., Putnam S.D., Kamal K.A., Rozmajzl P., et al. Clinic-based surveillance for bacterial- and rotavirus-associated diarrhea in Egyptian children. Am J Trop Med Hyg 2006, 74(January (1)):148-153.
30. Raes M., Strens D., Vergison A., Verghote M., Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011, 30(July (7)):e120-e125.
31. Tate J.E., Mutuc J.D., Panozzo C.A., Payne D.C., Cortese M.M., Cortes J.E., et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011, 30(January (1 Suppl.)):S30-S34.
32. Boom J.A., Tate J.E., Sahni L.C., Rench M.A., Quaye O., Mijatovic-Rustempasic S., et al. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J 2010, 29(December (12)):1133-1135.
33. Correia J.B., Patel M.M., Nakagomi O., Montenegro F.M., Germano E.M., Correia N.B., et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 2010, 201(February (3)):363-369.
34. de Palma O., Cruz L., Ramos H., de Baires A., Villatoro N., Pastor D., et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. Br Med J 2010, 340:c2825.
35. Patel M., Pedreira C., De Oliveira L.H., Tate J., Orozco M., Mercado J., et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. J Am Med Assoc 2009, 301(June (21)):2243-2251.
36. Yen C., Figueroa J.R., Uribe E.S., Carmen-Hernandez L.D., Tate J.E., Parashar U.D., et al. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico. J Infect Dis 2011, 204(August (5)):783-786.
37. World Health Organization (WHO) Global and national estimates of deaths under age five attributable to rotavirus infection: 2004 (as of 31 March 2006) 2010, Available at:, [accessed 16.06.10]. http://www.who.int/immunization_monitoring/burden/rotavirus_estimates/en/.